1 | Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation | Coautor: Rivas-delgado A., Bastidas-Mora G., Beà S., Navarro A., et al. | 2022 | BRITISH JOURNAL OF HAEMATOLOGY | WoS-id: 000695434400001 Scopus-id: 2-s2.0-85114837883
| 22 | 22 |
2 | Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma | Coautor: Rivas-delgado A., Dlouhy I., Karube K., Enjuanes A., et al. | 2022 | BRITISH JOURNAL OF HAEMATOLOGY | WoS-id: 000705122500001 Scopus-id: 2-s2.0-85116797465
| 5 | 6 |
3 | The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma | Coautor: Rivas-delgado A., Mozas P., Rivero A., Nadeu F., et al. | 2022 | LEUKEMIA & LYMPHOMA | WoS-id: 000724056800001 Scopus-id: 2-s2.0-85120358432
| 8 | 8 |
4 | First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma | Coautor: Rivas-delgado A., Mozas P., Rivero A., Correa J.G., et al. | 2022 | HEMATOL ONCOL | WoS-id: 000727565600001 Scopus-id: 2-s2.0-85120635768
| 0 | 0 |
5 | Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma | Coautor: Rivas-delgado A., Cortes J.R., Filip I., Albero R., et al. | 2022 | CELL REPORTS | WoS-id: 000792276800005 Scopus-id: 2-s2.0-85128399799
| 14 | 19 |
6 | Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma | 1ᵉʳ autor: Rivas-delgado A., Nadeu F., Andrade-Campos M., López C., et al. | 2022 | Diagnostics | WoS-id: 000833104700001 Scopus-id: 2-s2.0-85133502761
| 10 | 13 |
7 | Detection of early seeding of Richter transformation in chronic lymphocytic leukemia | Coautor: Rivas-delgado A., Nadeu F., Royo R., Massoni-Badosa R., et al. | 2022 | NATURE MEDICINE | WoS-id: 000839575100002 Scopus-id: 2-s2.0-85135812673
| 83 | 82 |
8 | A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma | Coautor: Rivas-delgado A., Mozas P., Rivero A., Nadeu F., et al. | 2021 | LEUKEMIA & LYMPHOMA | WoS-id: 000571323400001 Scopus-id: 2-s2.0-85091171625
| 10 | 10 |
9 | Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma | Coautor: Rivas-delgado A., Mozas P., Rivero A., Fabregat A., et al. | 2021 | BRITISH JOURNAL OF HAEMATOLOGY | WoS-id: 000589642100001 Scopus-id: 2-s2.0-85096672633
| 5 | 6 |
10 | The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients | Coautor: Rivas-delgado A., Mozas P., Sorigué M., Rivero A., et al. | 2021 | EUROPEAN JOURNAL OF HAEMATOLOGY | WoS-id: 000598382100001 Scopus-id: 2-s2.0-85100734648
| 2 | 2 |
11 | Mutational landscape and tumor burden assessed by cell-free DNA in diffuse large B-cell lymphoma in a population-based study | 1ᵉʳ autor: Rivas-delgado A., Nadeu F., Enjuanes A., Casanueva-Eliceiry S., et al. | 2021 | CLINICAL CANCER RESEARCH | WoS-id: 000617323400019 Scopus-id: 2-s2.0-85100279537
| 62 | 64 |
12 | Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma | Coautor: Rivas-delgado A., Mozas P., Rivero A., Nadeu F., et al. | 2021 | ANNALS OF HEMATOLOGY | WoS-id: 000621285400001 Scopus-id: 2-s2.0-85101577917
| 6 | 6 |
13 | The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma | Coautor: Rivas-delgado A., Valero J.G., Matas-Céspedes A., Arenas F., et al. | 2021 | Leukemia | WoS-id: 000629893400002 Scopus-id: 2-s2.0-85102993343
| 42 | 44 |
14 | Serum monoclonal component in chronic lymphocytic leukemia: Baseline correlations and prognostic impact | Coautor: Rivas-delgado A., Mozas P., Piñeyroa J.A., Nadeu F., et al. | 2021 | HAEMATOLOGICA | WoS-id: 000656912200002 Scopus-id: 2-s2.0-85095677107
| 4 | 4 |
15 | Clinicobiological characteristics and outcomes of patients with t-cell large granular lymphocytic leukemia and chronic lymphoproliferative disorder of natural killer cells from a single institution | Coautor: Rivas-delgado A., Rivero A., Mozas P., Jiménez L., et al. | 2021 | Cancers | WoS-id: 000681831800001 Scopus-id: 2-s2.0-85111455153
| 12 | 14 |
16 | Prognostic ability of five clinical risk scores in follicular lymphoma: A single-center evaluation | Coautor: Rivas-delgado A., Mozas P., Rivero A., Correa J.G., et al. | 2021 | HEMATOL ONCOL | WoS-id: 000693467500001 Scopus-id: 2-s2.0-85114342484
| 6 | 5 |
17 | Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience | Coautor: Rivas-delgado A., Mozas P., Nadeu F., Rivero A., et al. | 2020 | BLOOD CANCER J | WoS-id: 000518328000001 Scopus-id: 2-s2.0-85081228931
| 28 | 29 |
18 | IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms | Coautor: Rivas-delgado A., Nadeu F., Mas-de-les-Valls R., Navarro A., et al. | 2020 | NATURE COMMUNICATIONS | WoS-id: 000548309100009 Scopus-id: 2-s2.0-85087550795
| 27 | 28 |
19 | Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma | Coautor: Rivas-delgado A., Fuster C., Martín-Garcia D., Balagué O., et al. | 2020 | HAEMATOLOGICA | WoS-id: 000555707800007 Scopus-id: 2-s2.0-85084366780
| 16 | 19 |
20 | High serum levels of IL-2R, IL-6, and TNF-a are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era | 2ᵒ autor: Rivas-delgado A., Mozas P., Rivero A., Dlouhy I., et al. | 2020 | LEUKEMIA RESEARCH | WoS-id: 000564127700008 Scopus-id: 2-s2.0-85085278703
| 12 | 13 |
21 | PI3Kd inhibition reshapes follicular lymphoma?immune microenvironment cross talk and unleashes the activity of venetoclax | Coautor: Rivas-delgado A., Serrat N., Guerrero-Hernández M., Matas-Céspedes A., et al. | 2020 | Blood Advances | WoS-id: 000567426100019 Scopus-id: 2-s2.0-85091513700
| 27 | 29 |
22 | The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome | Coautor: Rivas-delgado A., Duran-Ferrer M., Clot G., Nadeu F., et al. | 2020 | Nature Cancer | WoS-id: 000614887500008 Scopus-id: 2-s2.0-85094883634
| 53 | 57 |
23 | Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era | 1ᵉʳ autor: Rivas-delgado A., Magnano L., Moreno-Velázquez M., García O., et al. | 2019 | BRITISH JOURNAL OF HAEMATOLOGY | WoS-id: 000458970900008 Scopus-id: 2-s2.0-85057756800
| 57 | 59 |
24 | Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population | Coautor: Rivas-delgado A., Magnano L., Alonso-Alvarez S., Alcoceba M., et al. | 2019 | BRITISH JOURNAL OF HAEMATOLOGY | WoS-id: 000465109900010 Scopus-id: 2-s2.0-85064479321
| 27 | 27 |
25 | Corrigendum: Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue (Annals of Oncology (2018) 29 (2363-2370) DOI: 10.1093/annonc/mdy450) | Coautor: Rivas-delgado A., Ciavarella S., Vegliante M.C., Fabbri M., et al. | 2019 | ANNALS OF ONCOLOGY | WoS-id: 000507595800024 Scopus-id: 2-s2.0-85077402370
| 13 | 13 |
26 | Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia | 2ᵒ autor: Rivas-delgado A., Mozas P., Baumann T., Villamor N., et al. | 2018 | BLOOD CANCER J | WoS-id: 000423723100001 Scopus-id: 2-s2.0-85040837659
| 4 | 3 |
27 | Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia? | Coautor: Rivas-delgado A., Ortiz-Maldonado V., Villamor N., Baumann T., et al. | 2018 | BRITISH JOURNAL OF HAEMATOLOGY | WoS-id: 000447750900016 Scopus-id: 2-s2.0-85055078425
| 7 | 9 |
28 | Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI | Coautor: Rivas-delgado A., Delgado J., Doubek M., Baumann T., et al. | 2017 | AM J HEMATOL | WoS-id: 000399299300022 Scopus-id: 2-s2.0-85012996204
| 76 | 85 |
29 | Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions | Coautor: Rivas-delgado A., Puiggros A., Collado R., Calasanz M.J., et al. | 2017 | Oncotarget | WoS-id: 000407826100033 Scopus-id: 2-s2.0-85028629855
| 35 | 42 |
30 | The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-?B mutational status | Coautor: Rivas-delgado A., Vidal-Crespo A., Rodriguez V., Matas-Céspedes A., et al. | 2017 | HAEMATOLOGICA | WoS-id: 000414069100006 Scopus-id: 2-s2.0-85032698302
| 16 | 18 |
31 | Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma | Coautor: Rivas-delgado A., Magnano L., Balagué O., Dlouhy I., et al. | 2017 | ANNALS OF ONCOLOGY | WoS-id: 000414493200024 Scopus-id: 2-s2.0-85034118134
| 20 | 24 |
32 | High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma | Coautor: Rivas-delgado A., Dlouhy I., Filella X., Rovira J., et al. | 2017 | LEUKEMIA RESEARCH | WoS-id: 000415601000004 Scopus-id: 2-s2.0-85019365472
| 40 | 46 |
33 | Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection | 1ᵉʳ autor: Rivas-delgado A., Matutes E., Rozman M. | 2016 | BRITISH JOURNAL OF HAEMATOLOGY | Scopus-id: 2-s2.0-84956947647
| 0 | 6 |
34 | Clinical impact of a 6-week preoperative very low calorie diet on body weight and liver size in morbidly obese patients | Coautor: Delgado A.R., González-Pérez J., Sánchez-Leenheer S., González-Vargas L., et al. | 2013 | OBESITY SURGERY | WoS-id: 000324230800019 Scopus-id: 2-s2.0-84884668997
| 40 | 41 |
35 | Potential Additional Effect of Omentectomy on Metabolic Syndrome, Acute-Phase Reactants, and Inflammatory Mediators in Grade III Obese Patients Undergoing Laparoscopic Roux-en-Y | Coautor: Rivas, A, Herrera, MF, Pantoja, JP, Velazquez-Fernandez, D, et al. | 2010 | Diabetes Care | WoS-id: 000282356800002 Scopus-id: 2-s2.0-77958176309
| 61 | 69 |